Search
Anifrolumab
go.drugbank.com/drugs/DB11976ApprovedInvestigationalerythematosus, but so far only anifrolumab has been approved. … [A237054] Anifrolumab has also been investigated for the treatment of Scleroderma.[A237044] Anifrolumab was granted FDA approval on 30 July 2021.[L34929]
Products: SAPHNELO 300MG CONCENTRATE FOR SOLUTION FOR INFUSIONSodium tartrate
go.drugbank.com/drugs/DB13707ApprovedWithdrawnSodium tartrate is a disodium salt of l-( + )-tartaric acid that is identified by transparent, colorless, and odorless crystals. It is obtained as a byproduct of wine manufacturing. … Sodium tartrate is generally recognized as safe (GRAS) as a direct human food ingredient. It acts as an emulsifier and pH control agent in food products [L2590].
Categories: Drugs for ConstipationSynonyms: Tartaric acid, disodium saltBlinatumomab
go.drugbank.com/drugs/DB09052ApprovedInvestigationalIt was first approved by the FDA in December 2014 for the treatment of CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL) in relapsed and refractory patients. … [L44311] Full approval for this indication was granted in June 2023.
Products: BLINCYTO POWDER FOR INFUSION 35 MCG/VIAL, BLINCYTO (Blinatumomab) for injection 35 mcg/vialNecitumumab
go.drugbank.com/drugs/DB09559ApprovedInvestigationalWithdrawnNecitumumab is approved for use in combination with cisplatin and gemcitabine as a first-line treatment for metastatic squamous non-small cell lung cancer (NSCLC). … It functions by binding to epidermal growth factor receptor (EGFR) and prevents binding of its ligands, a process that is involved in cell proliferation, metastasis, angiogenesis, and malignant progression
Products: PORTRAZZA CONCENTRATE FOR SOLUTION FOR INFUSION 800MG/50MLCorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
go.drugbank.com/drugs/DB10584ApprovedInvestigationalMixtures: , Suspension for Injection, ADACEL SUSPENSION FOR INJECTIONCategories: Antiinfectives for Systemic UseBimatoprost
go.drugbank.com/drugs/DB00905ApprovedInvestigationalBimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. … [L6910] It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug
Mixtures: GANFORT® UD SOLUCION OFTALMICAProducts: LUMIGAN® UDLutetium Lu 177 dotatate
go.drugbank.com/drugs/DB13985ApprovedInvestigationalLutetium Lu 177 dotatate was approved by the FDA as Lutathera in January 2018 for intravenous injection. … A 177Lu-labeled somatostatin analog peptide, Lutetium Lu 177 dotatate belongs to an emerging form of treatments called Peptide Receptor Radionuclide Therapy (PRRT), which involves targeting tumours with
Categories: Compounds used in a research, industrial, or household settingProducts: LUTATHERA SOLUTION FOR INFUSION 370 MBQ/MLMagnesium acetate
go.drugbank.com/drugs/DB13996ApprovedSynonyms: acetic acid magnesium salt, Acetic acid, magnesium salt (2:1)Brilliant green cation
go.drugbank.com/drugs/DB11279ApprovedVet approvedBrilliant green, or ethanaminium, is a derivative of triarylmethane dye that has been used as a dye to color silk and wool.
Categories: Compounds used in a research, industrial, or household settingSynonyms: Brilliant green, free formLutropin alfa
go.drugbank.com/drugs/DB00044ApprovedInvestigationalLutropin alfa was the first and only recombinant human form of luteinizing hormone (LH) developed for use in the stimulation of follicular development. … It is a heterodimeric glycoprotein made up of monomeric units.
Mixtures: Pergoveris 150IU/75IU powder and solvent for solution for injection, Pergoveris Powder and Solvent for Solution for Injection 150iu/75iuProducts: LUVERIS FOR INJECTION 75 iu/vial (Revised formula)